See more : Superior Plus Corp. (SUUIF) Income Statement Analysis – Financial Results
Complete financial analysis of Tilray Brands, Inc. (TLRY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tilray Brands, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Lyons Bancorp Inc. (LYBC) Income Statement Analysis – Financial Results
- New Found Gold Corp. (NFG.V) Income Statement Analysis – Financial Results
- Goodtech ASA (GOD.OL) Income Statement Analysis – Financial Results
- Norwood Financial Corp. (NWFL) Income Statement Analysis – Financial Results
- Winsome Textile Industries Limited (WINSOMTX.BO) Income Statement Analysis – Financial Results
Tilray Brands, Inc. (TLRY)
About Tilray Brands, Inc.
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 788.94M | 627.12M | 628.37M | 513.09M | 391.00M | 175.25M | 28.63M | 15.17M | 6.47M | 443.70K | 0.00 | 0.00 |
| Cost of Revenue | 565.59M | 480.16M | 511.56M | 389.90M | 253.31M | 119.50M | 3.97M | 2.33M | 1.88M | 567.59K | 0.00 | 0.00 |
| Gross Profit | 223.35M | 146.96M | 116.82M | 123.18M | 137.68M | 55.74M | 24.66M | 12.84M | 4.58M | -123.89K | 0.00 | 0.00 |
| Gross Profit Ratio | 28.31% | 23.43% | 18.59% | 24.01% | 35.21% | 31.81% | 86.13% | 84.63% | 70.87% | -27.92% | 0.00% | 0.00% |
| Research & Development | 635.00K | 682.00K | 1.52M | 830.00K | 1.85M | 1.03M | 380.00K | 365.52K | 168.99K | 55.95K | 0.00 | 0.00 |
| General & Administrative | 171.56M | 165.16M | 162.80M | 111.58M | 88.30M | 70.83M | 24.64M | 5.25M | 2.21M | 5.33M | 45.34K | 98.51K |
| Selling & Marketing | 79.17M | 65.78M | 65.86M | 44.12M | 29.92M | 20.67M | 9.21M | 4.95M | 2.76M | 579.52K | 0.00 | 0.00 |
| SG&A | 250.72M | 230.94M | 228.66M | 155.69M | 118.22M | 91.50M | 33.85M | 10.20M | 4.97M | 5.91M | 45.34K | 98.51K |
| Other Expenses | 146.74M | -66.91M | 115.19M | 35.22M | 15.68M | 10.41M | 1.98M | 379.96K | 277.37K | -3.28M | 0.00 | 0.00 |
| Operating Expenses | 398.10M | 325.11M | 345.37M | 191.74M | 135.75M | 102.94M | 37.32M | 11.28M | 5.42M | 6.01M | 45.34K | 98.51K |
| Cost & Expenses | 963.69M | 805.27M | 856.93M | 581.64M | 389.07M | 222.44M | 34.24M | 13.61M | 7.30M | 5.81M | 45.34K | 98.51K |
| Interest Income | 12.83M | 33.03M | 11.74M | 2.93M | 5.79M | 10.61M | 4.93M | 827.91K | 215.83K | 104.79K | 3.35K | 2.08K |
| Interest Expense | 49.26M | 13.59M | 39.68M | 30.90M | 24.78M | 5.75M | 1.05M | 287.34K | 215.83K | 104.79K | 3.35K | 2.08K |
| Depreciation & Amortization | 126.91M | 130.15M | 115.19M | 35.22M | 15.68M | 16.95M | 5.18M | 1.44M | 730.05K | 306.47K | 0.00 | 0.00 |
| EBITDA | -72.84M | -889.52M | -246.40M | -218.36M | -18.40M | -36.66M | -658.00K | 4.37M | 115.11K | -5.06M | -1.43M | -608.47K |
| EBITDA Ratio | -9.23% | -18.32% | 42.73% | 5.90% | 17.18% | 8.19% | -2.55% | 28.80% | -1.73% | -1,141.18% | 0.00% | 0.00% |
| Operating Income | -174.75M | -1.37B | 153.30M | -4.95M | 51.48M | -2.60M | -9.64M | -1.03M | -836.23K | -2.73M | -45.34K | -98.51K |
| Operating Income Ratio | -22.15% | -218.41% | 24.40% | -0.96% | 13.17% | -1.48% | -33.66% | -6.81% | -12.93% | -615.78% | 0.00% | 0.00% |
| Total Other Income/Expenses | -74.28M | -80.50M | 169.73M | -212.82M | -5.18M | 100.79M | 40.23M | 151.61K | 221.29K | -2.53M | 0.00 | 2.08K |
| Income Before Tax | -249.02M | -1.45B | -440.67M | -344.99M | -58.19M | -11.56M | 27.81M | 3.22M | -614.94K | -5.27M | -41.99K | -96.43K |
| Income Before Tax Ratio | -31.56% | -231.24% | -70.13% | -67.24% | -14.88% | -6.60% | 97.13% | 21.20% | -9.51% | -1,186.63% | 0.00% | 0.00% |
| Income Tax Expense | -26.62M | -7.18M | -6.54M | -8.97M | 2.82M | 631.19K | 4.97M | 99.29K | -920.06K | -3.38M | 0.00 | 0.00 |
| Net Income | -244.98M | -1.44B | -434.13M | -336.01M | -61.02M | -12.19M | 22.84M | 3.12M | 305.12K | -5.27M | -41.99K | -96.43K |
| Net Income Ratio | -31.05% | -230.10% | -69.09% | -65.49% | -15.61% | -6.96% | 79.77% | 20.54% | 4.72% | -1,186.63% | 0.00% | 0.00% |
| EPS | -0.33 | -2.34 | -0.90 | -1.25 | -0.61 | -0.06 | 0.17 | 0.04 | 0.01 | -0.14 | -0.01 | -0.04 |
| EPS Diluted | -0.33 | -2.34 | -0.90 | -1.25 | -0.61 | -0.06 | 0.16 | 0.04 | 0.01 | -0.14 | -0.01 | -0.04 |
| Weighted Avg Shares Out | 742.65M | 617.98M | 481.22M | 269.55M | 100.46M | 203.46M | 134.96M | 87.45M | 48.98M | 38.04M | 3.34M | 2.31M |
| Weighted Avg Shares Out (Dil) | 742.65M | 617.98M | 481.22M | 269.55M | 100.46M | 203.46M | 139.05M | 93.39M | 48.98M | 38.04M | 3.34M | 2.31M |
Cannabis stocks plunge after DeSantis, Griffin win Florida fight against weed legalization
Tilray Launches "Men's Health on Tap" Podcast: Acclaimed Doctors Engage in Empowering Discussions and Break Down Stigmas Around Men's Health Topics
Cannabis stocks tank as Florida votes against recreational marijuana
Top Canadian Cannabis Stocks to Track as U.S. Legalization Heats Up
3 Stocks That Have Generated Terrifying Returns for Investors Over the Past 5 Years
3 Marijuana Stocks For Today's Trader
Beyond Beer, Tilray's $1.67 Billion Market Play: Is This Cannabis Giant Still A Smart Buy?
EXCLUSIVE: Tilray CEO Irwin Simon On Why US Cannabis Rescheduling Won't Change A Billion-Dollar Play
Tilray Brands stock analysis: attractive risk/reward?
Breckenridge Brewery Unveils Annual Release of Funslinger Lager in Collaboration with Colorado Artist Mike Graves
Source: https://incomestatements.info
Category: Stock Reports